TALARIS THERAPEUTICS INC

$15.70 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About TALARIS THERAPEUTICS INC

Talaris Therapeutics, Inc. operates as a biotechnology company. The Company focuses on developing proprietary method of allogeneic hematopoietic stem cell transplantation for chronic immunosuppression and treat patients who suffer from autoimmune diseases and non-malignant blood, immune, and metabolic disorders. Talaris Therapeutics serves patients in the United States.

Stock Analysis

last close $15.41
1-mo return 7.4%
3-mo return 9.5%
avg daily vol. 39.24T
52-week high 19.82
52-week low 11.39
market cap. $641M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 70.7%
baraka

Subscribe now for daily local and international financial news

Subscribe